Shifting markets, government mandates, and the linking of insurance reimbursement with medical outcomes have all made the pharmaceutical industry to become more conservative when it comes to their expenditure. Therefore, pharmaceutical companies today are looking to come up with more cost-effective strategies while increasing the quality of care. Some of the general trends that are gaining traction in this space include single-use technology, continuous biopharma manufacturing, specialized requirements for highly potent active pharmaceutical ingredients (HPAPIs), an increased interest in the used equipment market, and so on.
Single-use/disposable technology has gained a lot of acceptance recently in biopharmaceutical drug development. This is primarily due to the decreased CapEx and operational costs that the disposables provide by reducing the cleaning and sterilization steps and eliminating validation. Besides, disposable technology has also enabled the implementation of fully integrated continuous biopharmaceutical production. This has resulted in the development of more consistent products and processes, which directly translates to the consumption of fewer resources and lesser waste generation, thereby reducing operating costs. Additionally, with an increasing number of antibody-drug conjugates either in production or in testing, there is also a need to manufacture specialized equipment that caters to the specific needs of the HPAPIs.
In an effort to help decision-makers identify the best pharma machinery solution provider, a panel of prominent CEOs, CIOs, VCs, analysts, along with the Pharma Tech Outlook’s editorial board has assessed scores of pharma machinery solution providers and shortlisted the prime ones. We have considered the vendor’s ability in designing and building advanced pharma machinery solutions that cater to the pharmaceutical companies’ needs.
We present to you Pharma Tech Outlook’s “Top 10 Pharma Machinery Providers - 2019.”